Diadem SpA and UT researchers unveiled a new antibody for early Alzheimer's detection at CTAD 2024.

Diadem SpA, in partnership with researchers from the University of Texas Medical Branch, presented significant findings on early Alzheimer's disease detection at the 2024 CTAD conference. They developed a U-p53AZ-specific antibody that identifies a misfolded variant of the p53 protein in brain tissue, distinguishing Alzheimer's patients from healthy individuals. This research highlights the antibody's potential for improving early diagnosis and therapeutic strategies for Alzheimer's disease.

November 01, 2024
3 Articles

Further Reading